References
- Mamani-Matsuda M, Kauss T, Al-Kharrat J, et al. Therapeutic and preventive properties of quercetin in experimental arthritis correlate with decreased macrophage inflammatory mediators. Biochem Pharmacol 2006;72:1304–10.
- Jakhar R, Paul S, Park YR, et al. 35,7,3′,4′-Pentamethoxyflavone, a quercetin derivative protects DNA from oxidative challenges: potential mechanism of action. J Photochem Photobiol B Biol 2014;131:96–103.
- Maalik A, Khan FA, Mumtaz A, et al. Pharmacological applications of quercetin and its derivatives: a short review. Trop J Pharm Res 2014;13:1561–6.
- Rotelli AE, Guardia T, Juarez AO, et al. Comparative study of flavonoids in experimental models of inflammation. Pharmacol Res 2003;48:601–6.
- Boots AW, Haenen GR, Bast A. Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol 2008;585:325–37.
- Harwood M, Danielewska-Nikiel B, Borzelleca JF, et al. A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties. Food Chem Toxicol 2007;45:2179–205.
- Ruiz MJ, Fernandez M, Pico Y, et al. Dietary administration of high doses of pterostilbene and quercetin to mice is not toxic. J Agric Food Chem 2009;57:3180–6.
- Gugler R, Leschik M, Dengler HJ. Disposition of quercetin in man after single oral and intravenous doses. Eur J Clin Pharmacol 1975;9:229–34.
- Khaled KA, El-Sayed YM, Al-Hadiya BM. Disposition of the flavonoid quercetin in rats after single intravenous and oral doses. Drug Dev Ind Pharm 2003;29:397–403.
- Hollman PC, Gaag M, Mengelers MJ, et al. Absorption and disposition kinetics of the dietary antioxidant quercetin in man. Free Radic Biol Med 1996;21:703–7.
- Serafini M, Peluso I, Raguzzini A. Flavonoids as anti-inflammatory agents. Proc Nutr Soc 2010;69:273–8.
- Gao Y, Wang Y, Ma Y, et al. Formulation optimization and in situ absorption in rat intestinal tract of quercetin-loaded microemulsion. Colloids Surf B Biointerfaces 2009;71:306–14.
- Dora CL, Silva LFC, Tagliari MP, et al. Formulation study of quercetin-loaded lipid-based nanocarriers obtained by hot solvent diffusion method. Lat Am J Pharm 2011;30:289–96.
- Dora CL, Putaux JL, Pignot-Paintrand I, et al. Physicochemical and morphological characterizations of glyceryl tristearate/castor oil nanocarriers prepared by the solvent diffusion method. J Braz Chem Soc 2012;23:1972–81.
- Dora CL, Silva LFC, Putaux JL, et al. Poly(ethylele glycol) hydroxystearate-based nanosized emulsion: effect of surfactant concentration on their formation and ability to solubilize quercetin. J Biomed Nanotechnol 2012;8:1–9.
- Li H, Zhao X, Ma Y, et al. Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles. J Control Release 2009;133:238–44.
- Barras A, Mezzetti A, Richard A, et al. Formulation and characterization of polyphenol-loaded lipid nanocapsules. Int J Pharm 2009;379:270–7.
- Date AA, Nagarsenker MS, Patere S, et al. Lecithin-based novel cationic nanocarriers (Leciplex) II: improving therapeutic efficacy of quercetin on oral administration. Mol Pharm 2011;8:716–26.
- Liu L, Tanga Y, Gao C, et al. Characterization and biodistribution in vivo of quercetin-loaded cationic nanostructured lipid carriers. Colloids Surf B Biointerfaces 2014;115:125–31.
- Rogerio AP, Dora CL, Andrade EL, et al. Anti-inflammatory effect of quercetin-loaded microemulsion in the airways allergic inflammatory model in mice. Pharmacol Res 2010;61:288–97.
- Durrieu V, Giandini A, Balcacem MN, et al. Preparation of aqueous anionic poly-(urethane-urea) dispersions: influence of the nature and proportion of the urethane groups on the dispersions and polymer properties. J Appl Polym Sci 2004;94:700–10.
- International Conference on Harmonization (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Harmonized Tripartite Guideline, Validation of Analytical Procedures: Text and Methodology, ICH-Q2 (R1), 2005 November, Geneva, Switzerland.
- Manrique-Moreno M, Howe J, Suwalsky M, et al. Physicochemical interaction study of non-steroidal anti-inflammatory drugs with dimyristoylphosphatidylethanolamine liposomes. Lett Drug Des Discov 2010;7:50–6.
- Tunc I. The effect of the presence of Ag nanoparticles on the photocatalytic degradation of oxalic acid adsorbed on TiO2 nanoparticles monitored by ATR-FTIR. Mater Chem Phys 2014;144:444–50.
- De Lima VR, Caro MSB, Munford ML, et al. Influence of melatonin on the order of phosphatidylcholine-based membranes. J Pineal Res 2010;49:169–75.
- Kan-zhi L, Jackson M, Sowa MG, et al. Modification of the extracellular matrix following myocardial infarction monitored by FTIR spectroscopy. Biochim Biophys Acta 1996;1315:73–7.
- Arsov Z, Quaroni L. Direct interaction between cholesterol and phosphatidylcholines in hydrated membranes revealed by ATR-FTIR spectroscopy. Chem Phys Lipids 2007;150:35–48.
- Peres I, Rocha S, Pereira MC, et al. NMR structural analysis of epigallocatechin gallate loaded polysaccharide nanoparticles. Carbohydr Polym 2010;82:861–6.
- Schwingel TE, Klein CP, Nicoletti NF, et al. Effects of the compounds resveratrol, rutin, quercetin, and quercetin nanoemulsion on oxaliplatin-induced hepatotoxicity and neurotoxicity in mice. Naunyn Schmiedebergs Arch Pharmacol 2014;387:837–48.
- McClements DL. Nanoemulsions versus microemulsions: terminology, differences, and similarities. Soft Matter 2012;8:1719–29.
- Heurtault B, Saulnier P, Pech B, et al. A novel phase inversion-based process for the preparation of lipid nanocarriers. Pharm Res 2002;19:875–80.
- Huynh NT, Passirani C, Saulnier P, Benoit JP. Lipid nanocapsules: a new platform for nanomedicine. Int J Pharm 2009;379:201–9.
- Heurtault B, Saulnier P, Pech B, et al. Physico-chemical stability of colloidal lipid particles. Biomaterials 2003;24:4283–300.
- Zhang X, Pan W, Gan L, et al. Preparation of a dispersible PEGylate nanostructured lipid carriers (NLC) loaded with 10-hydroxycamptothecin by spray-drying. Chem Pharm Bull 2008;56:1645–50.
- Morais JM, Burgess DJ. In vitro release testing methods for vitamin E nanoemulsions. Int J Pharm 2014;475:393–400.
- Ali MH, Moghaddan B, Kirby DJ, et al. The role of lipid geometry in designing liposomes for the solubilisation of poorly water soluble drugs. Int J Pharm 2013;453:225–32.
- Chen C, Tripp CP. An infrared spectroscopic based method to measure membrane permeance in liposomes. Biochim Biophys Acta 2008;1778:2266–72.